Dapagliflozin Krka

Dapagliflozin Krka is an oral medication used to manage blood sugar levels in adults with type 2 diabetes. It belongs to a class of drugs known as SGLT2 inhibitors, which help the kidneys remove excess glucose from the body.

Dapagliflozin Krka is primarily used to improve glycemic control in adults with type 2 diabetes. It works by inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys, which helps to increase the excretion of glucose through urine. This medication is often used alongside diet and exercise to manage blood sugar levels effectively. People often ask, 'What is Dapagliflozin used for?' and the answer is that it is used for managing type 2 diabetes.

Common effects of Dapagliflozin Krka may include increased urination, thirst, and a higher risk of urinary tract infections. Some individuals may also experience dizziness or lightheadedness, especially when standing up quickly. It is important to stay hydrated while taking this medication to help mitigate these effects.

Dapagliflozin Krka should be handled with care, especially for those with a history of kidney problems or dehydration. It is essential to monitor kidney function regularly and maintain adequate hydration. Patients should also be aware of the signs of low blood sugar, such as sweating, dizziness, and confusion, although this medication is less likely to cause hypoglycemia compared to other diabetes treatments.

Dapagliflozin Krka may interact with certain medications, including diuretics, insulin, and other drugs that lower blood sugar. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it can increase the risk of low blood sugar and dehydration.